Peptides are suddenly everywhere. Injectable peptide therapies promising faster recovery and a longer life. Peptide serums promising firmer skin. Clinics built around personalised peptide protocols, introduced as though the entire category had been invented in the last two years. It had not. And one of the oldest immune strategies in nature, passing immune information from one generation to the next, has been sitting in plain sight the whole time, with small peptide-sized molecules called Intelligent Peptides among the carriers science has described.
What are peptides, and why is everyone suddenly talking about them?
A peptide is a short chain of amino acids, small enough to work as a signal rather than as a building block. Peptides tell cells what to do: repair, calm down, defend, divide. The body produces a great many of them, and has done so for as long as there have been bodies. They are also part of how the immune system communicates with the rest of the body.
What has changed is the manufacturing. Pharmaceutical and cosmetic science can now produce synthetic versions of these signals, and a wave of clinics, serums and supplements has formed around them. The underlying biology is old. The marketing is what is new.
Are all peptides the same?
No, and the differences matter more than most labels admit. Size decides whether a peptide can reach its target at all. For skin, the long-standing rule of thumb is that substances above roughly 500 Daltons struggle to cross the outer barrier (Bos and Meinardi, 2000), and research on transdermal drug delivery has spent decades working around exactly that limit. A peptide named on a label is not automatically a peptide that arrives where it is supposed to work.
Dosing, stability and delivery are also still open questions for many of the newest products, and long-term evidence is thin for much of the category. That does not make synthetic peptides useless. It does mean that confident marketing and proven benefit are two different things.
What makes Intelligent Peptides different from synthetic peptides?
The science behind Intelligent Peptides began in 1955, when Henry Sherwood Lawrence showed that an extract of disrupted white blood cells could pass a specific immune reaction from one person to another (Lawrence, 1955). Since then they have been characterised as small immune-signalling molecules rather than antibodies, a body of knowledge summarised in Kirkpatrick, 1993.
The way they are described differs from a typical synthetic peptide. A synthetic peptide is usually engineered to do one narrow job: bind a single receptor or switch on a single pathway. Intelligent Peptides are described as carrying information, which the immune system can use to recognise a specific threat more accurately and to settle down once the threat has passed. Think less of an instruction to do more, and more of better information to work with, the kind of cellular-level immune information I wrote about in Intelligent Molecules.
That distinction matters. An immune system pushed to do more is not automatically a healthier one: autoimmune conditions and severe allergies are, in a sense, immune systems doing too much rather than too little.
How has immune information been passed between generations?
Biology solved a version of this problem long before laboratories existed: how does a mother pass immune experience to offspring that have not had time to earn any? And it solved it again and again, in very different branches of life.
In mammals, the route runs through colostrum, the first milk produced after birth. It is rich in immunoglobulins, immune cells and signalling molecules (Playford and Weiser, 2021), including secretory IgA, the body’s first line of immune defence at mucosal surfaces. In birds, hens load their eggs with antibodies, so chicks hatch carrying their mother’s immune experience (Hamal et al., 2006). Across vertebrates, maternal antibodies reach the offspring through the placenta, the egg yolk or the milk (Hasselquist and Nilsson, 2009). Even plants do it: the descendants of plants that were primed by a pathogen are better prepared against that same threat (Slaughter et al., 2012; Luna et al., 2012).
Intelligent Peptides belong to this story. Their activity has been described in colostrum, including bovine colostrum (Wilson et al., 1988), and in egg yolk, where a small fraction below 12 kilodaltons from the yolks of immunised hens carried antigen-specific cell-mediated immune activity (Xu et al., 2006).
The principle is the same wherever it appears. A newborn’s immune system does not start from a blank page. It inherits a head start, delivered in the first days of life, or before birth or hatching, through mechanisms that are among the most widespread in the living world. This is not a human peculiarity. It is a strategy evolution arrived at repeatedly, in mammals, in birds and even in plants.
What does this mean for immune support and longevity?
Longevity conversations tend to centre on extending years. A more useful question may be what fills those years, and an immune system that recognises threats accurately, without overreacting to harmless ones, sits close to the foundation of that. Chronic, low-grade inflammation is one of the more consistent threads in research on ageing, a pattern researchers call inflammaging (Franceschi et al., 2000), and part of the broader science of healthy ageing.
Supporting the immune system with information it has relied on for generations is not a trend-chasing position. It is closer to the opposite: leaning on a system with the longest track record available, rather than the newest one with the shortest.
None of this is an argument against scientific progress. Synthetic peptides may well prove valuable once their delivery, dosing and safety questions are answered. It is an argument for noticing that new and proven are different claims, and for asking a simple question the next time peptides come up as the newest thing in wellness: new compared with what? Your own immune system has been running one of the originals for a very long time.
None of this replaces sleep, movement, good food or medical care. It adds one more category to a health conversation that rarely asks how the immune system learns.
With love and positivity,
Jennifer🙏🏻💛
